🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III, randomized, two arms, double-blind (patient and assess...
Status
Completed
Location
Shafa Hospital
Start Date
2016-10-04
Trial ID
NCT03288987
Treatments Being Tested
The annual incidence of sudden sensorineural hearing loss (SSNHL) is 5 to 2...
Status
Not Yet Recruiting
Location
Lariboisière Hospital
Start Date
2026-04-01
Trial ID
NCT07113158
Treatments Being Tested
It is expected that addition of anti-CD20 antibody - ofatumumab would enhan...
Status
Completed
Location
Dolnośląskie Centrum Transplantacji Komórkowych
Start Date
2011-11
Trial ID
NCT01481272
The goal of this Phase 3 clinical trial is to evaluate whether continuing c...
Status
Recruiting
Location
A.O.U. Ospedali Riuniti
Start Date
2025-10-01
Trial ID
NCT07389265
The causes of malnutrition are complex and addressing the problem requires ...
Status
Completed
Location
Ethiopia Public Health Institute
Start Date
2020-12-28
Trial ID
NCT04694898
Treatments Being Tested
Therefore preterm infants must need folic acid replacement than term babies...
Status
Completed
Location
Zekai Tahir Burak Maternity Teaching Hospital, Neonatology Unit
Start Date
2011-02
Trial ID
NCT01360528
Our objective was to investigate the importance of malaria infection/diseas...
Status
Completed
Location
Centre Muraz
Start Date
2003-06
Trial ID
NCT00680732
Erlotinib may stop the growth of tumor cells by blocking the enzymes necess...
Status
Completed
Location
Johns Hopkins University
Start Date
2003-06
Trial ID
NCT00060411
Treatments Being Tested
QUILT-3.088 NANT Pancreatic Cancer Vaccine: Phase II Randomized Trial of th...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-08
Trial ID
NCT03563144
Mirvetuximab soravtansine (MIRV) is an antibody-drug conjugate approved for...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-20
Trial ID
NCT07690332
Treatments Being Tested